MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. (MPLT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mplt · stock forecast · 2 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$48.00
Consensus
$43.00
+46.0% upside
Low
$36.00
Median: $44 · Last Close: $29.46
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$43.00
46.0% upside
High Target
$48
62.9%
Low Target
$36
22.2%
Current Price
$29.46
as of today
Based on analyst price targets, the MPLT stock price prediction for the next 12 months ranges from $36 to $48. The consensus MPLT price forecast of $43.00 implies 46.0% upside from the current price of $29.46.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $29.12 | ↓ 1.16% |
1-day model range: $28.88–$29.36. Peak: $29.36 (-1.16%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MPLT · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-02 | Stifel | Maintains | Buy→Buy |
| 2026-05-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on MapLight Therapeutics, Inc. (MPLT) stock. Of the recent 2 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover MPLT.
Analyst Recommendation Trends
MPLT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
Revenue Next Year
$0M
EPS This Year
$-4.93
EPS Next Year
$-4.26
↓ 13.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast MPLT EPS of $-4.93 for the current fiscal year, based on estimates from 7 analysts. The MPLT revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MPLT stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MPLT price target is $43.00 (+46.0% upside), with an analyst consensus of Buy.
The MPLT short-term stock prediction for tomorrow is $29.12 (-1.16%).
MapLight Therapeutics, Inc. trades on NASDAQ under the ticker MPLT. The MPLT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
MPLT forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month MPLT price target is $43.00, with a high forecast of $48.00 and a low of $36.00. The median price target is shown in the chart above when available. This implies +46.0% potential upside from the current price of $29.46.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.